Analysen zu Carl Zeiss Meditec AG
| 08.05.24 | Carl Zeiss Meditec Outperform | RBC Capital Markets | |
| 08.05.24 | Carl Zeiss Meditec Buy | UBS AG | |
| 24.04.24 | Carl Zeiss Meditec Buy | UBS AG | |
| 16.04.24 | Carl Zeiss Meditec Kaufen | DZ BANK | |
| 12.04.24 | Carl Zeiss Meditec Buy | UBS AG | |
| 27.03.24 | Carl Zeiss Meditec Outperform | RBC Capital Markets | |
| 14.03.24 | Carl Zeiss Meditec Outperform | RBC Capital Markets | |
| 27.02.24 | Carl Zeiss Meditec Buy | Hauck & Aufhäuser Privatbankiers KGaA | |
| 13.02.24 | Carl Zeiss Meditec Buy | UBS AG | |
| 12.02.24 | Carl Zeiss Meditec Buy | Hauck & Aufhäuser Privatbankiers KGaA | |
| 09.02.24 | Carl Zeiss Meditec Buy | UBS AG |
Aktuelle Aktienanalysen
| 05.02.26 | Deutsche Telekom Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.02.26 | Shell Kaufen | DZ BANK | |
| 05.02.26 | BMW Hold | Jefferies & Company Inc. | |
| 05.02.26 | BMW Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | London Stock Exchange Outperform | RBC Capital Markets | |
| 05.02.26 | OMV buy | UBS AG | |
| 05.02.26 | RATIONAL Overweight | Barclays Capital | |
| 05.02.26 | Hannover Rück Buy | Jefferies & Company Inc. | |
| 05.02.26 | Hannover Rück Kaufen | DZ BANK | |
| 05.02.26 | Evonik Equal Weight | Barclays Capital | |
| 05.02.26 | BNP Paribas Buy | UBS AG | |
| 05.02.26 | Vodafone Group Sell | UBS AG | |
| 05.02.26 | Santander Buy | UBS AG | |
| 05.02.26 | ArcelorMittal Neutral | UBS AG | |
| 05.02.26 | Hannover Rück Buy | UBS AG | |
| 05.02.26 | Shell Neutral | UBS AG | |
| 05.02.26 | Prosus Buy | UBS AG | |
| 05.02.26 | BBVA Buy | UBS AG | |
| 05.02.26 | RATIONAL Buy | UBS AG | |
| 05.02.26 | Siemens Healthineers Neutral | UBS AG | |
| 05.02.26 | Evonik Sell | Goldman Sachs Group Inc. | |
| 05.02.26 | BNP Paribas Outperform | RBC Capital Markets | |
| 05.02.26 | Hannover Rück Sector Perform | RBC Capital Markets | |
| 05.02.26 | Shell Sector Perform | RBC Capital Markets | |
| 05.02.26 | RATIONAL Underperform | RBC Capital Markets | |
| 05.02.26 | Vestas Wind Systems A-S Outperform | RBC Capital Markets | |
| 05.02.26 | Santander Halten | DZ BANK | |
| 05.02.26 | UBS Kaufen | DZ BANK | |
| 05.02.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 05.02.26 | Saint-Gobain Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | BNP Paribas Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | BBVA Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | Vodafone Group Underweight | JP Morgan Chase & Co. | |
| 05.02.26 | Hannover Rück Neutral | JP Morgan Chase & Co. | |
| 05.02.26 | Vestas Wind Systems A-S Overweight | JP Morgan Chase & Co. | |
| 05.02.26 | Ferrari Overweight | Barclays Capital | |
| 05.02.26 | Beiersdorf Overweight | Barclays Capital | |
| 05.02.26 | Heidelberg Materials Overweight | Barclays Capital | |
| 05.02.26 | Bayer Overweight | Barclays Capital | |
| 05.02.26 | Siemens Healthineers Overweight | Barclays Capital | |
| 05.02.26 | Rheinmetall Overweight | Barclays Capital | |
| 05.02.26 | Hannover Rück Underweight | Barclays Capital | |
| 05.02.26 | Evonik Underperform | Jefferies & Company Inc. | |
| 05.02.26 | RATIONAL Outperform | Bernstein Research | |
| 05.02.26 | Linde Outperform | Bernstein Research | |
| 05.02.26 | Akzo Nobel Market-Perform | Bernstein Research | |
| 05.02.26 | BASF Outperform | Bernstein Research | |
| 05.02.26 | ArcelorMittal Hold | Jefferies & Company Inc. | |
| 05.02.26 | Siemens Healthineers Buy | Jefferies & Company Inc. | |
| 05.02.26 | Hannover Rück Buy | Jefferies & Company Inc. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.